Jose R. Conejo-Garcia

Affiliations: 
Immunology and Microbiology Dartmouth College, Hanover, NH, United States 
Area:
Immunology, Molecular Biology, Oncology
Google:
"Jose Conejo-Garcia"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cao Y, Trillo-Tinoco J, Sierra RA, et al. (2019) Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nature Communications. 10: 3680
Cao Y, Trillo-Tinoco J, Sierra RA, et al. (2019) ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nature Communications. 10: 1280
Singh V, Yeoh BS, Chassaing B, et al. (2018) Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer. Cell. 175: 679-694.e22
Song M, Sandoval TA, Chae CS, et al. (2018) IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature
Perales-Puchalt A, Perez-Sanz J, Payne KK, et al. (2018) Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy. Journal of Leukocyte Biology
Tchou J, Zhao Y, Levine BL, et al. (2017) Safety and efficacy of intratumoral injections of chimeric antigen receptor (CAR) T cells in metastatic breast cancer. Cancer Immunology Research
Allegrezza MJ, Rutkowski MR, Stephen TL, et al. (2016) Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological Myelopoiesis. Cancer Research. 76: 6253-6265
Svoronos N, Perales-Puchalt A, Allegrezza MJ, et al. (2016) Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Supressor Cells. Cancer Discovery
Zhu H, Bengsch F, Svoronos N, et al. (2016) BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression. Cell Reports. 16: 2829-2837
Perales-Puchalt A, Svoronos N, Rutkowski MR, et al. (2016) FOLLICLE-STIMULATING HORMONE RECEPTOR IS EXPRESSED BY MOST OVARIAN CANCER SUBTYPES AND IS A SAFE AND EFFECTIVE IMMUNOTHERAPEUTIC TARGET. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
See more...